Specifically, in vitro experiment using trastuzumab on HER2+ BC cells showed no PD-L1 overexpression; however, when the same cells were co-cultured with human peripheral blood mononuclear cells (PBMCs), PD-L1 overexpression was noted. This evidence concerns the gene ERBB2 and breast cancer.